Tyra Biosciences (TYRA) Other Accumulated Expenses (2020 - 2026)

Tyra Biosciences (TYRA) has 7 years of Other Accumulated Expenses data on file, last reported at $15.1 million in Q1 2026.

• Quarterly Other Accumulated Expenses rose 33.62% year-over-year to $15.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.1 million (up 33.62% YoY) and the FY2025 annual result came in at $16.4 million, up 20.98% from the prior year.
• Other Accumulated Expenses declined to $15.1 million in Q1 2026, from $16.4 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $16.4 million in Q4 2025 to a low of $2.3 million in Q1 2023.
• A 5-year average of $8.4 million and a median of $8.4 million in 2024 frame the typical range for Other Accumulated Expenses.
• The widest YoY moves for Other Accumulated Expenses: up 194.11% in 2023, down 34.09% in 2023.
• Tracing TYRA's Other Accumulated Expenses over 5 years: stood at $4.4 million in 2022, then soared by 135.3% to $10.4 million in 2023, then jumped by 30.81% to $13.6 million in 2024, then increased by 20.98% to $16.4 million in 2025, then retreated by 8.02% to $15.1 million in 2026.
• The last three Other Accumulated Expenses figures came in at $15.1 million (Q1 2026), $16.4 million (Q4 2025), and $13.4 million (Q3 2025), per Business Quant data.